TITLE:
Oral Enzastaurin HCl in Patients With Relapsed Mantle Cell Lymphoma

CONDITION:
Mantle-Cell Lymphoma

INTERVENTION:
enzastaurin

SUMMARY:

      The purposes of this study are to determine the safety of oral enzastaurin HCl and any side
      effects that might be associated with it and whether enzastaurin HCl can help patients with
      Mantle Cell Lymphoma.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 18 Years to N/A
Criteria:

        Inclusion Criteria:

          -  Mantle Cell Lymphoma

          -  Previous treatment for Mantle Cell Lymphoma

          -  Adequate organ function

        Exclusion Criteria:

          -  Inability to swallow tablets

          -  Must not have had more than 3 prior treatments for Mantle Cell Lymphoma

          -  Must not have significant heart problems
      
